☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
$660M
Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to STADA for ~$660M
November 5, 2019
Smith & Nephew to Acquire Osiris Therapeutics for $660M
March 14, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
